Cancer News and Research

Latest Cancer News and Research

Immunovia's new blood-based testing platform accurately detects non-small cell lung cancer

Immunovia AB announced today that in a new collaborative study with a major global pharma company, Immunovia ́s innovative blood-based testing platform, IMMray could differentiate healthy controls from non-small cell lung cancer samples with a 95 % accuracy.

14 Aug 2018

Scientists identify mutational signatures in ovarian cancer

Scientists have identified distinct patterns of genetic mutation among patients with ovarian cancer that could help them personalise treatment in the future.

14 Aug 2018

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

More than two-thirds of women with ovarian cancer have high-grade serous carcinoma. Up to 90 percent of HGSCs are not detected until they are beyond the ovaries or fallopian tubes, at which point it may not be possible to fully remove the tumor.

14 Aug 2018

New strategy accelerates, automates process of prototype molecule optimization

The search for new medicinal molecules with predetermined properties is a rather complex, expensive and time-consuming process, especially in oncology.

14 Aug 2018

Keck Medicine of USC's hospitals ranked among nation's best for the 10th consecutive year

For the 10th consecutive year, Keck Medicine of USC's hospitals have been ranked among the country's Best Hospitals by U.S. News & World Report.

14 Aug 2018

Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells

More than 100 years ago, German Nobel laureate Paul Ehrlich popularized the "magic bullet" concept -- a method that clinicians might one day use to target invading microbes without harming other parts of the body. Although chemotherapies have been highly useful as targeted treatments for cancer, unwanted side effects still plague patients.

14 Aug 2018

Brown University researchers reveal key physical properties of 'giant' cancer cells

Polyploidal cancer cells--cells that have more than two copies of each chromosome--are much larger than most other cancer cells, are resistant to chemotherapy and radiation treatments and are associated with disease relapse.

14 Aug 2018

New technology shows potential to streamline the analysis of proteins

New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.

14 Aug 2018

University Hospitals Seidman Cancer Center launches new CAR-T therapy trial

University Hospitals Seidman Cancer Center launched a new clinical trial for CAR-T, joining a select group of hospitals offering the therapy and a smaller group of hospitals manufacturing the CAR-T cells.

14 Aug 2018

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.

14 Aug 2018

Study finds quality of doctor-patient discussions about lung cancer screening to be 'poor'

Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.

14 Aug 2018

Duke researchers track missing T-cells in glioblastoma patients

Glioblastoma brain tumors can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses.

13 Aug 2018

New genome analysis could identify people at higher risk of common deadly diseases

A research team at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and Harvard Medical School reports a new kind of genome analysis that could identify large fractions of the population who have a much higher risk of developing serious common diseases, including coronary artery disease, breast cancer, or type 2 diabetes.

13 Aug 2018

Scientists discover key vulnerability of mixed lineage leukemia

Childhood leukemia is a diagnosis that no family ever wants to endure. While the treatment of most types of leukemia has improved steadily over the years, a few specific types remain very difficult to treat.

13 Aug 2018

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.

13 Aug 2018

Scientists discover biomarker for kidney cancer

Scientists have discovered a new blood biomarker that could help predict the risk of kidney cancer.

13 Aug 2018

New test predicts the risk of serious disease months before symptoms appear

Researchers have developed a new genetic test that can identify people who are at an increased risk of serious disease, long before they develop any symptoms.

13 Aug 2018

Researchers discover secret communication hotline between breast cancers and normal cells

Australian researchers have uncovered a secret communication hotline between breast cancers and the normal cells surrounding them. Importantly, the messages sent back and forth between the normal and tumour cells encourage the cancer to survive and to become more aggressive.

13 Aug 2018

New marker in the blood could help predict person's risk of developing kidney cancer

Scientists have discovered that a marker in the blood could help predict the risk that a person will develop kidney cancer, according to research published in the journal Clinical Cancer Research.

13 Aug 2018

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients

A multidisciplinary team of researchers from the National University of Singapore (NUS) has developed an artificial intelligence technology platform that could potentially change the way drug combinations are being designed, hence enabling doctors to determine the most effective drug combination for a patient quickly.

13 Aug 2018

Cancer News and Research

Latest Cancer News and Research

Immunovia's new blood-based testing platform accurately detects non-small cell lung cancer

Scientists identify mutational signatures in ovarian cancer

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

New strategy accelerates, automates process of prototype molecule optimization

Keck Medicine of USC's hospitals ranked among nation's best for the 10th consecutive year

Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells

Brown University researchers reveal key physical properties of 'giant' cancer cells

New technology shows potential to streamline the analysis of proteins

University Hospitals Seidman Cancer Center launches new CAR-T therapy trial

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

Study finds quality of doctor-patient discussions about lung cancer screening to be 'poor'

Duke researchers track missing T-cells in glioblastoma patients

New genome analysis could identify people at higher risk of common deadly diseases

Scientists discover key vulnerability of mixed lineage leukemia

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Scientists discover biomarker for kidney cancer

New test predicts the risk of serious disease months before symptoms appear

Researchers discover secret communication hotline between breast cancers and normal cells

New marker in the blood could help predict person's risk of developing kidney cancer

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in